Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Note
-
Reference no. 9-807-050
Published by: Harvard Business Publishing
Originally published in: 2007
Version: 25 January 2007
Revision date: 14-Jan-2020
Length: 23 pages
Data source: Published sources

Abstract

Describes the US FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.

About

Abstract

Describes the US FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.

Settings


Related